Boston Scientific Corporation Stock

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 16:00:02 2024-04-26 EDT 5-day change 1st Jan Change
73.17 USD -0.12% Intraday chart for Boston Scientific Corporation +8.67% +26.57%
Sales 2024 * 15.98B 21.84B Sales 2025 * 17.49B 23.9B Capitalization 108B 147B
Net income 2024 * 2.14B 2.93B Net income 2025 * 2.68B 3.66B EV / Sales 2024 * 7.11 x
Net Debt 2024 * 6.01B 8.22B Net Debt 2025 * 3.35B 4.58B EV / Sales 2025 * 6.34 x
P/E ratio 2024 *
50.8 x
P/E ratio 2025 *
41.1 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.12%
1 week+8.67%
Current month+6.83%
1 month+7.70%
3 months+19.70%
6 months+46.99%
Current year+26.57%
More quotes
1 week
66.80
Extreme 66.8
74.39
1 month
66.80
Extreme 66.8
74.39
Current year
57.11
Extreme 57.11
74.39
1 year
48.35
Extreme 48.35
74.39
3 years
34.98
Extreme 34.98
74.39
5 years
24.10
Extreme 24.1
74.39
10 years
11.10
Extreme 11.1
74.39
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
Director/Board Member 72 14-02-28
More insiders
Date Price Change Volume
24-04-26 73.17 -0.12% 8,786,294
24-04-25 73.26 +0.48% 8,172,200
24-04-24 72.91 +5.68% 15,276,470
24-04-23 68.99 +1.43% 9,075,682
24-04-22 68.02 +1.02% 7,659,790

Delayed Quote Nyse, April 26, 2024 at 04:00 pm

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
73.17 USD
Average target price
80.08 USD
Spread / Average Target
+9.44%
Consensus